Therapeutic effect of Songlingxuemaikang capsule in elderly patients with stable angina

VernacularTitle:松龄血脉康胶囊治疗老年稳定性心绞痛临床观察
Author: Zhimei JIA ; Wenyan JIANG ; Zhijun JIA
Publication Type:Journal Article
Keywords: Angina pectoris; Drugs,chinese hebal
From: Chinese Journal of General Practitioners 2011;10(4):275-276
CountryChina
Language:Chinese
Abstract: Eighty two patients aged 60 or over with stable angina pectoris were randomized to control group ( n = 42, receiving conventional western medicine) and treatment group ( n = 40, receiving 1.5 g Songlingxuemaikang capsules three times a day in addition to western medicine) .The treatment was lasted for 12 weeks, angina classification of CCS, hs-CRP, blood pressure levels and SF-36 (36-item short form)of the patients were evaluated before and after the treatment.The degrees of angina pectoris in angina classification of CCS, hs-CRP and blood pressure levels decreased, and the quality of life was improved in both groups; but more markedly in treatment group than those in control group (P ＜ 0.05 ).Songlingxuemaikang capsule combined with conventional western medicine can effectively relieve the symptoms of ischemic chest pain in elderly patients with stable angina pectoris, which is associated with blood pressure reduction and life quality improvement.